KEYTRUDA 25 mg/mL concentrate for solution for infusion, MK-3475A
MK-3475A-F11
Phase 2 small_molecule active
Quick answer
KEYTRUDA 25 mg/mL concentrate for solution for infusion, MK-3475A for Melanoma, Renal Cell Carcinoma, Non-small cell lung cancer is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Melanoma, Renal Cell Carcinoma, Non-small cell lung cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active